A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis.
A 2-year safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis